News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
396,523 Results
Type
Article (18871)
Company Profile (114)
Press Release (377538)
Section
Business (121007)
Career Advice (710)
Deals (23588)
Drug Delivery (79)
Drug Development (56290)
Employer Resources (67)
FDA (9801)
Job Trends (8560)
News (214289)
Policy (19867)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (4)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (905)
Adcomms (11)
Allergies (49)
Alliances (30133)
ALS (58)
Alzheimer's disease (806)
Antibody-drug conjugate (ADC) (64)
Approvals (9837)
Artificial intelligence (154)
Autoimmune disease (13)
Automation (5)
Bankruptcy (225)
Best Places to Work (6611)
BIOSECURE Act (9)
Biosimilars (60)
Biotechnology (51)
Bladder cancer (47)
Brain cancer (18)
Breast cancer (143)
Cancer (1317)
Cardiovascular disease (108)
Career advice (621)
Career pathing (12)
CAR-T (92)
Cell therapy (249)
Cervical cancer (14)
Clinical research (47016)
Collaboration (477)
Compensation (196)
Complete response letters (19)
COVID-19 (1210)
CRISPR (29)
C-suite (138)
Cystic fibrosis (55)
Data (1421)
Denatured (15)
Depression (23)
Diabetes (151)
Diagnostics (3117)
Digital health (5)
Diversity (3)
Diversity, equity & inclusion (19)
Drug discovery (76)
Drug pricing (79)
Drug shortages (22)
Duchenne muscular dystrophy (63)
Earnings (51279)
Editorial (18)
Employer branding (5)
Employer resources (58)
Events (57110)
Executive appointments (432)
FDA (10563)
Featured Employer (22)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (374)
Gene editing (67)
Generative AI (13)
Gene therapy (188)
GLP-1 (430)
Government (2116)
Grass and pollen (3)
Guidances (34)
Healthcare (8304)
Huntington's disease (7)
IgA nephropathy (19)
Immunology and inflammation (57)
Indications (24)
Infectious disease (1279)
Inflammatory bowel disease (88)
Inflation Reduction Act (7)
Influenza (26)
Intellectual property (64)
Interviews (98)
IPO (10869)
IRA (34)
Job creations (2314)
Job search strategy (553)
Kidney cancer (7)
Labor market (13)
Layoffs (202)
Leadership (5)
Legal (4398)
Liver cancer (42)
Lung cancer (189)
Lymphoma (98)
Machine learning (2)
Management (22)
Manufacturing (186)
MASH (50)
Medical device (5432)
Medtech (5435)
Mergers & acquisitions (13110)
Metabolic disorders (406)
Multiple sclerosis (47)
NASH (16)
Neurodegenerative disease (43)
Neuropsychiatric disorders (7)
Neuroscience (1121)
NextGen: Class of 2025 (2682)
Non-profit (1204)
Northern California (1501)
Now hiring (7)
Obesity (216)
Opinion (155)
Ovarian cancer (60)
Pain (67)
Pancreatic cancer (51)
Parkinson's disease (93)
Partnered (10)
Patents (163)
Patient recruitment (63)
Peanut (22)
People (35098)
Pharmaceutical (67)
Pharmacy benefit managers (14)
Phase I (14189)
Phase II (20636)
Phase III (16047)
Pipeline (814)
Podcasts (47)
Policy (73)
Postmarket research (1642)
Preclinical (5524)
Press Release (32)
Prostate cancer (64)
Psychedelics (17)
Radiopharmaceuticals (169)
Rare diseases (241)
Real estate (3179)
Recruiting (23)
Regulatory (14596)
Reports (19)
Research institute (944)
Resumes & cover letters (89)
Rett syndrome (3)
RNA editing (3)
RSV (17)
Schizophrenia (50)
Series A (67)
Series B (36)
Service/supplier (5)
Sickle cell disease (42)
Southern California (1370)
Special edition (7)
Spinal muscular atrophy (90)
Sponsored (19)
Startups (1988)
State (2)
Stomach cancer (8)
Supply chain (40)
The Weekly (30)
United States (13454)
Vaccines (257)
Venture capitalists (18)
Webinars (11)
Weight loss (143)
Women's health (11)
Worklife (7)
Date
Today (94)
Last 7 days (513)
Last 30 days (1894)
Last 365 days (22226)
2025 (5429)
2024 (23161)
2023 (26081)
2022 (33043)
2021 (34274)
2020 (32185)
2019 (23605)
2018 (17975)
2017 (20129)
2016 (18370)
2015 (22004)
2014 (16825)
2013 (13797)
2012 (14600)
2011 (15378)
2010 (14158)
Location
Africa (421)
Alabama (24)
Alaska (3)
Arizona (89)
Arkansas (6)
Asia (28319)
Australia (5718)
California (3441)
Canada (1358)
China (360)
Colorado (163)
Connecticut (178)
Delaware (85)
Europe (54395)
Florida (541)
Georgia (90)
Idaho (14)
Illinois (288)
India (21)
Indiana (182)
Iowa (1)
Japan (116)
Kansas (63)
Kentucky (14)
Louisiana (4)
Maine (36)
Maryland (478)
Massachusetts (2697)
Michigan (71)
Minnesota (164)
Missouri (48)
Montana (12)
Nebraska (14)
Nevada (41)
New Hampshire (42)
New Jersey (1199)
New Mexico (10)
New York (1059)
North Carolina (606)
North Dakota (3)
Northern California (1501)
Ohio (88)
Oklahoma (4)
Oregon (21)
Pennsylvania (849)
Puerto Rico (8)
Rhode Island (12)
South America (665)
South Carolina (10)
Southern California (1370)
Tennessee (65)
Texas (518)
Utah (83)
Virginia (98)
Washington D.C. (36)
Washington State (375)
West Virginia (2)
Wisconsin (22)
396,523 Results for "telix pharmaceuticals limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.
ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed.
April 11, 2024
·
3 min read
Press Releases
Telix Adds Lead-212 Isotope Production Capability
March 13, 2025
·
6 min read
Press Releases
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
March 3, 2025
·
5 min read
Deals
Telix Announces Launch of Proposed Initial Public Offering in the United States
Telix Pharmaceuticals Limited (the “Company” or “Telix”) today announces the launch of its initial public offering in the United States (the “Offering”) of 17,000,000 American Depositary Shares (“ADSs”), each representing one ordinary share in Telix.
June 5, 2024
·
6 min read
Press Releases
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
·
8 min read
Press Releases
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
April 1, 2025
·
8 min read
Press Releases
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
February 13, 2025
·
8 min read
Deals
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
QSAM Biosciences Inc. (OTCQB: QSAM) (“QSAM or the “Company”) has signed a definitive Agreement and Plan of Merger (the “Agreement”) providing for the acquisition of the Company by Telix Pharmaceuticals Limited (ASX: TLX) (“Telix”).
February 7, 2024
·
8 min read
Telix Submits NDA for New Prostate Cancer Imaging Agent
Telix Pharmaceuticals Limited announces it has submitted a New Drug Application to the United States Food and Drug Administration for TLX007-CDx, a new and proprietary cold kit for the preparation of PSMA-PET imaging1 for prostate cancer.
May 28, 2024
·
7 min read
Press Releases
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 30, 2025
·
10 min read
1 of 39,653
Next
